manibiotech,
One thing even you must acknowledge and that is that Sawston represents a scalable model for manufacturing once Edens is fully validated and who needs a sales force when every cancer patient in the world is going to want this treatment for their cancer. At that point money comes from everywhere willing to help with the buildout and skilled labor and leadership coming from those most impacted will not be in short supply. As far as additional research, NWBO has contacts with the best in the world and their SAB will be considered second to none.
I believe Linda has a transition plan which may include a partner but she is full of surprises and just like Laura Posner obviously reminds me of a younger Linda, I’m certain Linda has a few folks in mind for any and all contemplated next steps.
Don’t think for a minute that she won’t wait for the true value of Direct and proteomics data to materialize before handing over the keys. Best wishes.
Market Data 
Markets 
AI
